TY - JOUR T1 - Twelve-month outcomes of the loozit randomized controlled trial: A community-based healthy lifestyle program for overweight and obese adolescents AU - Nguyen B, Shrewsbury VA, O’Connor J, et al Y1 - 2012/02/01 N1 - 10.1001/archpediatrics.2011.841 JO - Archives of Pediatrics & Adolescent Medicine SP - 170 EP - 177 VL - 166 IS - 2 N2 - Objectives  To assess the outcomes of the Loozit adolescent weight management intervention and to evaluate the effect of additional therapeutic contact 12 months into the program.Design  A 24-month, 2-arm randomized controlled trial. Results at 12 months are presented.Setting  Community health center and children's hospital in Sydney, Australia.Participants  A total of 151 overweight or obese 13- to 16-year-olds.Intervention  In the first 2 months (phase 1), participants received 7 adolescent and parent weekly sessions focused on lifestyle modification. From 2 to 24 months (phase 2), adolescents attended booster sessions once every 3 months. During phase 2, adolescents randomized to the additional therapeutic contact arm also received telephone coaching and electronic communications once every 2 weeks.Outcome Measures  Baseline to 12-month changes in body mass index z score and waist to height ratio (primary outcomes) and changes in metabolic, psychosocial, and behavioral variables.Results  Of 151 randomized adolescents, 82.1% completed 12-month follow-up. Intent-to-treat analyses showed significant reductions in mean body mass index z score (−0.09; 95% CI, −0.12 to −0.06), waist to height ratio (−0.02; 95% CI, −0.03 to −0.01), total cholesterol level (−4 mg/dL; 95% CI, −8 to 0 mg/dL; to convert to millimoles per liter, multiply by 0.0259), and triglycerides level (geometric mean, −80 mg/dL; 95% CI, −88 to −71 mg/dL; to convert to millimoles per liter, multiply by 0.0113). Most psychosocial outcomes improved, including global self-worth, but there were few dietary, physical activity, or sedentary behavior changes. No difference was found in primary outcomes between participants who did or did not receive additional therapeutic contact.Conclusions  The Loozit randomized controlled trial produced a significant but modest reduction in body mass index z score and improved psychosocial outcomes at 12 months. Supplementary telephone and electronic contact provided no additional benefit at 12 months.Trial Registration  anzctr.org.au Identifier: 12606000175572 SN - 1072-4710 M3 - doi: 10.1001/archpediatrics.2011.841 UR - http://dx.doi.org/10.1001/archpediatrics.2011.841 ER -